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Background: Interpretation of observational studies on associations between prefrontal
cognitive functioning and hormone levels across the female menstrual cycle is
complicated due to small sample sizes and poor replicability.
Methods: This observational multisite study comprised data of n = 88 menstruating
women from Hannover, Germany, and Zurich, Switzerland, assessed during a first
cycle and n = 68 re-assessed during a second cycle to rule out practice effects and
false-positive chance findings. We assessed visuospatial working memory, attention,
cognitive bias and hormone levels at four consecutive time-points across both cycles.
In addition to inter-individual differences we examined intra-individual change over time
(i.e., within-subject effects).
Results: Estrogen, progesterone and testosterone did not relate to inter-individual
differences in cognitive functioning. There was a significant negative association between
intra-individual change in progesterone and change in working memory from pre-
ovulatory to mid-luteal phase during the first cycle, but that association did not replicate in
the second cycle. Intra-individual change in testosterone related negatively to change in
cognitive bias from menstrual to pre-ovulatory as well as from pre-ovulatory to mid-luteal
phase in the first cycle, but these associations did not replicate in the second cycle.
Conclusions: There is no consistent association between women’s hormone levels, in
particular estrogen and progesterone, and attention, working memory and cognitive bias.
Leeners et al. Sex Hormones and Cognitive Functioning
That is, anecdotal findings observed during the first cycle did not replicate in the second
cycle, suggesting that these are false-positives attributable to random variation and
systematic biases such as practice effects. Due to methodological limitations, positive
findings in the published literature must be interpreted with reservation.
Keywords: hormones, cognition, menstrual cycle, working memory, attention, cognitive bias, estrogen,
progesterone
INTRODUCTION
In the scientific literature, female sex hormones and the
menstrual cycle have been linked to cognitive performance
(Farage et al., 2008; Sherwin, 2012). The main tenet of this
work is that sexually dimorphic cognitive skills that favor
men (i.e., visuospatial tasks) are improved during menstrual
phases with low estrogen and/or progesterone, while skills that
favor women (i.e., verbal tasks) are improved during phases
of high estrogen/progesterone. This work has been extended
to test prefrontal cortex functions and along these lines it has
been suggested that estrogens may be significantly involved in
attention and working memory ( e.g. Solis-Ortiz and Corsi-
Cabrera, 2008; Hatta and Nagaya, 2009; Jacobs and D’Esposito,
2011). However, a variety of studies found no or inconsistent
associations, as recently detailed in a comprehensive review and
synthesis of the literature (Sundstrom Poromaa and Gingnell,
2014). Moreover, there are growing concerns that various
positive associations reported in the literature could be true
null associations, that is, methodological artifacts and chance
findings (Ioannidis, 2005; Rosmalen and Oldehinkel, 2011;
Ferguson and Heene, 2012; Hengartner, 2017). In support of this
notion it has been demonstrated that due to scientific biases,
first, false-positive findings are ubiquitous, second, that inflated
effect sizes are common and, third, that the reproducibility
of results is generally low in psychological and biomedical
research (e.g., Kriegeskorte et al., 2009; Prinz et al., 2011; Ritchie
et al., 2012; Button et al., 2013; Macleod et al., 2014; Open
Science Collaboration, 2015; Muller et al., 2017). The ongoing
question is therefore, whether the fluctuations of female sex
hormones across the menstrual cycle really influence attention
and working memory in a consistent way or whether these
positive findings are spurious false-positives due to scientific
fallacies and methodological biases.
As recently reviewed, most published studies failed to
find meaningful and consistent associations between hormones
and cognitive functioning in women (Sundstrom Poromaa
and Gingnell, 2014). One reason for the inconsistencies
between findings is that cross-sectional studies (e.g., Halari
et al., 2005; Hampson and Morley, 2013) do not allow for
drawing stringent conclusions and that many longitudinal
studies relied on only two measurements (e.g., Maki et al.,
2002; Schoning et al., 2007; Hatta and Nagaya, 2009; Jacobs
and D’Esposito, 2011). An additional major source of bias
within the field are the utterly small sample sizes, which
commonly include less than 30 women (e.g., Maki et al., 2002;
Schoning et al., 2007; Jacobs and D’Esposito, 2011), and in
some highly-cited studies even less than 10 (e.g., Hausmann
et al., 2000; Solis-Ortiz et al., 2004; Solis-Ortiz and Corsi-
Cabrera, 2008). As comprehensively reviewed by Button et al.
(2013), underpowered small samples substantially undermine
the reliability of research findings by producing severely inflated
effect sizes and both false-positive and false-negative results.
Various studies also made speculative inferences from cycle
phase on hormone levels without actually reporting a correlation
between hormones and cognition (e.g., Rosenberg and Park,
2002; Solis-Ortiz et al., 2004; Solis-Ortiz and Corsi-Cabrera,
2008). Such inferences are problematic because inter-individual
variance in hormone levels at particular phases of the cycle
is tremendous (Sundstrom Poromaa and Gingnell, 2014). That
is, it must not be concluded that inter-individual differences
between cognitive functioning and cycle phase is causally
related to estrogen simply because, for instance, estrogen is
on average higher around ovulation than premenstrually, since
a substantial portion of women have higher estrogen levels
premenstrually than at ovulation. A stringent test would be
to examine whether intra-individual change from ovulatory to
premenstrual phase relates to changes in cognitive functioning.
If not, then a causal relationship is unlikely, but unfortunately
intra-individual change has hardly been considered in this
field. Of major concern are also reporting and publication
biases, which prevent the dissemination of negative findings
and which lead to severe overestimation of associations in
the published literature (Ioannidis et al., 2014). Thus, there
is apparently a gap between the actual meaning of research
findings and conclusions drawn in some narrative reviews and
original studies. In view of the methodological shortcomings in
the literature on associations between hormones and cognitive
abilities detailed above, methodologically sound observational
studies are necessary.
To come at reliable and valid estimates, larger samples
(i.e., preferably n > 50) more fine-grained designs (i.e., 4
repeated measurements across the cycle), more sophisticated
statistical modeling (examination of intra-individual change) and
replication of results (i.e. using data from a second cycle) are
required. We thus postulate the following four propositions
for a reliable and meaningful finding: Firstly, there needs to
be evidence for significant differences in cognitive functioning
across the cycle (inter-individually and specifically intra-
individually). Secondly, between-subject differences in hormone
levels must relate to differences in cognitive abilities at specific
cycle phases. Thirdly, these effects need to replicate in significant
associations between intra-individual change in hormone levels
and cognitive abilities across the cycle. Fourthly, significant
effects must replicate in data obtained from a second menstrual
cycle to exclude practice effects and false-positive chance
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findings. The aim of the present work was to critically examine,
whether prefrontal cortex functions such as working memory,
attention and cognitive control relate to serum hormone levels.
A recent review suggested that these cognitive functions may
correlate positively with estrogen and progesterone (Sundstrom
Poromaa and Gingnell, 2014), but due to the inconsistencies
and methodological limitations in the literature on associations
between cognitive functioning and hormones detailed above, we
did not a priori postulate specific hypotheses.
METHODS
Participants and Design
The study was designed as a prospective observational
study investigating serial measurements of hormonal and
neurocognitive parameters in healthy women and women with
endocrine disorders aged 18–40 years in up to two menstrual
cycles. Data were collected from 88 menstruating women. Of
those women, 58 presented no endocrinological pathology, 13
were diagnosed with endometriosis, 16 with polycystic ovary
syndrome (PCOS) and one woman with hyperprolactinemia.
Also, 12 women presented with obesity (defined as BMI >
30.0). Altogether 50 women were recruited at the Department
of Psychiatry, Social psychiatry and psychotherapy, Medical
School Hannover, Germany, and 38 women at the Clinic for
Reproductive Endocrinology, University Hospital Zurich,
Switzerland. All women with endometriosis, PCOS or
hyperprolactinemia were recruited in Zurich. Word of mouth,
direct invitation of eligible women in the consultations of the
Clinic for Reproductive Endocrinology, University hospital
Zurich, Switzerland and by gynecologists specialized in
gynecological endocrinology as well as advertisement on the
hospital and university boards were used for recruitment. A
total of 68 women were re-assessed during a second menstrual
cycle (Hannover: n = 47; Zurich: n = 21). For every completed
cycle, participants received 600 Swiss Francs (at Zurich study
site) or 500 Euros (at Hannover study site). As assessed before
the first index cycle, the mean age was 30.2 years (SD = 5.5)
and ranged from 20 to 40 years. The mean BMI was 25.0 (SD
= 5.4) and ranged from 17.7 to 45.7. A total of n = 31 (34.4%)
were married and n = 27 (30.0%) had children. Finally, n =
27 (30.3%) had a university degree. This study followed the
guidelines of the World Medical Association Declaration of
Helsinki 1964, updated in October 2013 and was conducted
after approval by the Ethics Committee of Hannover and Zurich
for investigations involving human subjects. All participants
provided written informed consent. Women were compensated
for their expenditures associated with study participation. The
study has been registered in clin.trial.gov (NCT02098668).
During a baseline visit women were interviewed to verify
inclusion and exclusion criteria and a physical examination
was performed to exclude medical conditions which might
influence hormone levels or cognitive performance except for
endometriosis, PCOS or hyperprolactinemia. Women were
excluded if they were using oral contraceptives, had been
pregnant or breastfeeding within the past 6 months, were
using medication or had surgery which might interfere with
endocrine parameters, had severe psychiatric or general diseases,
worked irregular shifts, had menstrual or ovulation disorders
except those investigated in the study (endometriosis, PCOS
and hyperprolactinemia) and if they showed any additional
abnormality in hormonal parameters (LH, FSH, estradiol,
progesterone, testosterone, prolactin, fasting glucose, fasting
insulin, thyroid stimulating hormone and in Zurich also anti-
Millerian hormone) taken cycle day 2–5 in the cycle following
the clinical screening examinations.
Hormone Measurements and Assays
For each woman with a cycle length of 28 ± 4 days a series
of 8 measurements of hormonal parameters was scheduled at
predefined days of the cycle (at cycle day 4, 7, 9, or 10, 12,
13, 17, 21, 28). At the first measurement and within 3–5 days
prior to the earliest anticipated day of ovulation based on the
menstrual history of the six previous cycles a first transvaginal
ultrasound was performed to exclude any cysts interfering with
the menstrual cycle. A second ultrasound was performed around
cycle day 11 to measure follicular development in order to
place the pre-ovulatory measurement as precise as possible.
When no dominant follicle could be demonstrated in the second
ultrasound control additional measurements were performed in
4–5 day intervals until follicular development could be confirmed
or cycle day 30 was reached. Ovulation tests based on urine
LH measurements (Evial Ovulationstest Midstream, Inopharm
GmbH, Muri, Switzerland and Clearblue digital Ovulationstest,
SPD Swiss Precision Diagnostics GmbH, Geneva, Switzerland)
were used to confirm the day of ovulation. These tests were
started either 5 days prior to the earliest ovulation based on
the previous 6 cycles or when a 14 mm follicle was seen
through transvaginal ultrasound. At each visit blood samples
were collected for hormonal assessment between 7.00 and 10.00
a.m. At four time points e.g., cycle day 2–5 (menstrual), pre-
ovulatory, mid-luteal and premenstrual the participants took
neuropsychological tests in addition to blood sampling.
In Hannover blood samples were initially frozen at −30◦C
and then stored at −80◦C. In Zürich blood samples were sent to
the laboratory immediately after the sample was collected in the
morning. To avoid bias due to different laboratory procedures
all samples were analyzed by the laboratory in Zürich. Estradiol
was measured using electrochemiluminescence immunoassays
ECLIA (Elecsys R© Estradiol II) based on polyclonal antibody
(Roche Diagnostics GmbH, Penzberg, Germany) with a
functional assay sensitivity of 44 pmol/L and a coefficient of
variation (CV%) of less than 7.7%. From January 15th 2015,
the ECLIA (Elecsys R© Estradiol III) based on monoclonal
antibody (Roche Diagnostics GmbH, Penzberg, Germany) with
a functional assay sensitivity to 91.8 pmol/L (25 pg/mL) and
CV% to less than 3.36% was applied. The measurement of
LH, FSH, progesterone, testosterone, TSH, and prolactin were
performed using electrochemiluminescence immunoassays
(ECLIA) applied on Cobas e-602 immunoassay autoanalyzer
(Roche Diagnostics GmbH, Penzberg, Germany).
The functional analytical assay sensitivity for LH, FSH,
progesterone, testosterone, TSH, and prolactin was 0.1 IU/L,
0.1 mIU/L, 0.48 nmol/L, 0.416 nmol/L, 0.014 mIU/L, and 1.00
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µIU/mL (0.047 ng/mL), respectively. Total imprecision (intra-
assay and inter-assay) of each assay was assessed by measuring
20 replicates of quality control samples over 20 days. Total
imprecision expressed as coefficient of variation (CV%) for LH,
FSH, progesterone, testosterone, TSH, and prolactin was less than
2.2, 2.1, 5.1, 3.9, 2.5, and 1.3 respectively. All analyses described in
this section were performed at the Institute of Clinical Chemistry,
University Hospital Zurich. For all methods, external quality
controls were carried out at regular intervals by the society for
promoting quality assurance in medical laboratories (INSTAND,
Duesseldorf, Germany) and Reference Institute for Bioanalytics
(RfB, Bone, Germany).
Neuropsychological Tests
Cognitive tests were performed using a standardized, validated,
computer-assisted test system developed by Candit.com
(CANDIT: Computer Assisted Neuropsychological Diagnostics
and Therapy). The neuropsychological tests were performed on
a touch screen computer; the same model was used in Hannover
and Zurich. Ten CANDIT tests were performed by each subject
in total and the overall test time was approximately 40 min.
The test categories included attention (comprising Cancellation
Screen Short, CPT Visual Short, and Divided Attention Bimodal
Task), visual memory (Blockspan forwards and backwards)
and executive functions tests (Cognitive Bias Test). These tests
(and their adaptations) were applied in previous research on
associations between cognitive functioning, hormones and cycle
phases (e.g., Mordecai et al., 2008; Solis-Ortiz and Corsi-Cabrera,
2008; Hampson and Morley, 2013). The other 5 tests were
created or adapted from standardized CANDIT tests and these
categories ranged from food cravings (Food Craving), dyadic
coping (Implicit Dyadic Coping), reactions to sexual stimuli
(Emotional Cognitive Bias Test and Rating of Sexual Stimuli)
and emotions (Situation Rating). Due to parsimony and in order
to avoid redundancy and false-positives due to multiple testing,
for the present paper we randomly chose one test out of the three
attention tests, that is, the divided attention test. Food craving,
implicit dyadic coping, as well as sexual stimuli and emotion
tests were excluded from the present study because they do not
assess prefrontal cognitive abilities. Participants were placed in
a quiet room to complete all the tests with a trained study staff
member present to explain the tests and answer any questions
that might arise during the test.
The Blockspan test is a well-established tool to investigate
visuospatial working memory (Vandierendonck et al., 2004;
Doucet et al., 2013) by requiring forward and backward recall of
path presentations. This test is also known as the Corsi blocks
task. In short, for the block task a set of 9 identical blocks is
presented on a monitor. Upon presentation of a series of blocks,
which change their color in a consecutive order, a representation
of the path has to be constructed and maintained in visual-spatial
working memory. The sequence then has to be reproduced in
the same (phase 1) or in reverse order (phase 2). To reproduce
the reverse order executive control is required (Vandierendonck
et al., 2004; Alvarez-Moya et al., 2011).
The Cognitive Bias Test (CBT) is a multiple choice procedure
designed by Goldberg et al. (1994) as a bias (preference) to
evaluate complex cognitive functions. The CBT entails designs
characterized along five binary dimensions: shape (circle/square),
color (red/blue), number (one/two identical components), size
(large/small), and contour (outline/filled with a homogeneous
color). Study participants have to rate similarity between two
items. The items are on different levels of difficulty and presented
twice in different vertical positions to the study participant. Thus,
32 stimuli can be generated, and a “similarity index” computed
between any two stimuli, ranging from 5 (identical) to 0 (differing
along all five dimensions). The “similarity indices” between
targets and subject’s choices are summed across trials (Goldberg
et al., 1994). In the present study we used correct responses as
the outcome, that is, higher scores on the CBT indicate better
cognitive control.
The Divided Attention Bimodal Task investigates the ability
to control visual and auditory stimuli simultaneously, hence,
divided attention. The study participant has to react to predefined
visual as well as auditory cues as quick as possible. For each fitting
visual cue a specific tab has to be pressed with the left hand and
for each fitting auditory cue a specific tab has to be pressed with
the right hand. The test includes three test phases, each including
a series of 35 items and takes about 5.15 min to be performed
(Parasuraman, 1998).
Statistical Analysis
The associations between repeated measures of cognitive
functioning and hormone levels were estimated using
Generalized Estimating Equations (GEE). These statistical
models were introduced to fit regression analyses that account
for within-subject correlation, which is an inherent part of
longitudinal studies that rely on repeated outcome measures
(Zeger et al., 1988). GEE are considered state of the art for
longitudinal data analysis and superior to repeated measures
ANOVA due to their psychometric properties (Ballinger, 2004;
Gibbons et al., 2010). GEE use all available data and impute
missing values under the assumption of Missing Completely at
Random (MCAR). Repeated measures of cognitive test scores
were successively entered as the outcome variables and the
hormone measures separately as predictor variables. Because all
cognitive test scores were approximately normally distributed,
we fitted all models with normal distribution and identity link-
function. The within-subject covariance was specified with the
“unstructured” correlation type to avoid having any constraints
on the covariance structure and a robust sandwich estimator was
used to reduce the effects of outliers and influential observations.
In addition to inter-individual differences at specific cycle
phases, we computed a longitudinal intra-individual change
model (Twisk, 2003). In such a model, only within-subject effects
are considered by including relative change values between
consecutive measurements of both the outcome variable and the
predictor variable instead of absolute values for each time-point.
Following Twisk (2003), in these change models the covariance
structure was specified as “independent.” Results were reported
with standardized regression coefficients (β) and their standard
errors (SE). In bivariate analyses these correspond to an effect
size r. We used two-tailed significance testing and Bonferroni
correction for multiple testing was applied to reduce the α-error
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rate. The Bonferroni-corrected significance level was α = 0.008.
All analyses were performed with SPSS 23 for Windows.
RESULTS
Distributions of hormone levels were carefully screened using
boxplots and extreme outliers (defined as a value 3 times higher
than the 75th percentile) were excluded from the analysis. Such
extreme hormone levels concerned 1–2 women per hormone
assessed. The fluctuating levels of hormones across the menstrual
cycle are indicated in Figure 1. A detailed account of the
exact number of assays at each cycle phase, range, means and
standard deviations for all hormone measures is provided in
the Supplementary Table 1. A total of n = 4 and n = 3
women, respectively, had an anovulatory cycle at first and second
menstrual cycle. Excluding these women did not alter the results
reported below; therefore they were included in the analysis.
There was evidence for significant variation in mean test
scores across the first cycle for cognitive bias and divided
attention and for blockspan forwards across the second cycle (see
Table 1). A detailed examination of intra-individual change in
cognitive functioning across both cycles is provided in Table 2.
Again we found significant effects in cognitive bias and divided
attention across the first cycle, indicating that scores in cognitive
bias increased intra-individually from early to late follicular
phase, whereas scores in divided attention increased from early
to late follicular phase as well as from late follicular to early luteal
phase. Adjusting for obesity or endocrinological disorders did not
alter the results. Moreover, neither obesity, nor endometriosis
or PCOS were significantly associated with cognitive functions
in the multivariable models. During the second cycle, there
was a significant change from early to late follicular phase in
cognitive bias and from early to late luteal phase in blockspan
forwards.
Associations between inter-individual differences in cognitive
ability and hormone levels across the first cycle are reported
in Table 3. Significant parameters were only considered when
the overall model effect was statistically significant at α =
0.05. Testosterone related significantly across measurements
to blockspan backwards (p = 0.031), but when Bonferroni
correction for multiple testing was applied, no single parameter
met statistical significance (all p> 0.008). FSH related negatively
to divided attention at premenstrual phase of the first cycle (β
= −0.29, p = 0.003). That association held when additionally
adjusted for overweight, endometriosis or PCOS. Using data
from the second menstrual cycle, we opted to replicate that
association. However, at premenstrual phase of the second cycle,
FSH was unrelated to divided attention, that is, the association
did not replicate (β=−0.01, SE= 0.11, p= 0.895).
Changes in cognitive functioning between consecutive time-
points in association with changes in estrogen, progesterone,
LH, FSH, and testosterone levels are indicated in Table 4. A
significant association between changes in progesterone and
blockspan backwards was found from pre-ovulatory to mid-
luteal phase during the first cycle (β = −0.44, p = 0.002). That
association held when adjusted for obesity and endocrinological
disorders. However, in the second cycle these parameters were
unrelated (β=−0.15, SE= 0.15, p= 0.332). As for testosterone, a
significant negative association with divided attention was found
for intra-individual change frommenstrual to pre-ovulatory (β=
−0.24, p = 0.007) as well as from pre-ovulatory to premenstrual
phase (β = −0.34, p = 0.007). These two associations remained
unaltered when adjusted for obesity, endometriosis or PCOS, but
they did not replicate using data from the second cycle (β= 0.00,
SE= 0.17, p= 0.995 for menstrual to pre-ovulatory change and β
=−0.20, SE= 0.20, p= 0.326 for pre-ovulatory to premenstrual
change).
Finally, we performed a subset analysis for healthy women
only (excluding all women with obesity or endocrinological
disorder). As there was no evidence for any consistent association
between sex hormones and prefrontal cognitive functions across
both cycles, for the sake of parsimony, here we report the
results for estrogen only. In the first cycle (n = 46), we noted
that estrogen significantly related to blockspan backward and
cognitive bias (both model effects p < 0.001). Specifically, both
blockspan backward (β = −0.59, SE = 13, p < 0.001) and
cognitive bias (β = −0.50, SE = 10, p < 0.001) were negatively
associated with estrogen at mid-luteal phase only. In contrast, in
the second cycle (n = 40), estrogen did not relate to blockspan
backward (model effect p = 0.459) and cognitive bias (model
effect p = 0.424). With respect to intra-individual change, in
the first cycle there was an association between estrogen and
cognitive bias (model effect p = 0.004), specifically a negative
association with change from mid-luteal to premenstrual phase
(β = −0.42, SE = 0.13, p = 0.001). Again, that association did
not replicate in the second cycle (model effect p= 0.821).
DISCUSSION
This multisite observational study used a stringent design
including a relatively large sample size, four different
measurement occasions across the cycle, statistical modeling
of intra-individual change scores over time, and an attempt
to replicate findings from the first cycle using data from a
second cycle, to critically examine a possible association between
hormone levels and prefrontal cognitive functioning, including
working memory, attention and cognitive control (i.e., cognitive
bias).
Most importantly, our data revealed no association
between estrogen and prefrontal cognitive functions across
two consecutive menstrual cycles, including between- and
within-subject effects. Note that these null-associations are not
a consequence of power failure, as effect sizes were consistently
small (all r < 0.3). These results conflict with some cross-
sectional findings (e.g., Hampson and Morley, 2013), but are
in accord with some longitudinal observational studies in
menstruating women (e.g., Mordecai et al., 2008; Griksiene and
Ruksenas, 2011). Moreover, large randomized controlled trials
in women making the transition to menopause (e.g., Espeland
et al., 2004; Henderson et al., 2016) did not detect practically
significant associations between estrogen therapy and cognitive
ability in women without cognitive impairments at baseline.
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FIGURE 1 | Mean hormone levels with standard deviations across the first menstrual cycle.
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TABLE 1 | Prefrontal cognitive test scores across two menstrual cycles.
Cognitive Test Measurement occasion Model effect
Menstrual Pre-ovulatory Mid-luteal Premenstrual
Mean (SE) Mean (SE) Mean (SE) Mean (SE) p
CYCLE 1
Blockspan forwards 5.82 (0.17) 6.07 (0.13) 6.14 (0.13) 6.15 (0.14) 0.198
Blockspan backwards 5.97 (0.08) 5.91 (0.06) 5.91 (0.08) 5.95 (0.08) 0.801
Cognitive bias 33.62 (0.34) 34.77 (0.32) 34.55 (0.35) 34.36 (0.38) 0.006
Divided attention 95.41 (0.53) 96.95 (0.67) 98.54 (0.59) 97.96 (0.64) <0.001
CYCLE 2
Blockspan forwards 6.07 (0.14) 6.30 (0.16) 6.13 (0.14) 6.60 (0.12) 0.001
Blockspan backwards 5.93 (0.08) 5.73 (0.12) 5.96 (0.10) 5.66 (0.12) 0.059
Cognitive bias 34.02 (0.56) 34.99 (0.45) 35.02 (0.53) 34.94 (0.52) 0.050
Divided attention 98.12 (0.65) 97.82 (0.73) 98.34 (0.76) 98.00 (0.91) 0.829
TABLE 2 | Mean intra-individual changes in prefrontal cognitive test scores across
two menstrual cycles.
Cognitive Test Measurement occasion Model effect
T1 thru T2 T2 thru T3 T3 thru T4
Mean (SE) Mean (SE) Mean (SE) p
CYCLE 1
Blockspan forwards 0.30 (0.18) 0.00 (0.12) 0.02 (0.14) 0.424
Blockspan backwards −0.04 (0.09) 0.02 (0.09) 0.02 (0.10) 0.861
Cognitive bias 1.27 (0.33)* −0.24 (0.30) −0.11 (0.29) 0.002
Divided attention 2.11 (0.67)* 1.21 (0.60)* −0.59 (0.75) 0.023
CYCLE 2
Blockspan forwards 0.24 (0.20) −0.11 (0.15) 0.58 (0.14)* 0.008
Blockspan backwards −0.10 (0.12) 0.15 (0.12) −0.24 (0.13) 0.177
Cognitive bias 0.77 (0.35)* 0.13 (0.33) 0.02 (0.32) 0.273
Divided attention 0.58 (0.59) 0.66 (0.56) −0.27 (0.68) 0.523
*Change score significantly different from zero.
T1, Menstrual phase; T2, pre-ovulatory phase; T3, mid-luteal phase; T4, premenstrual
phase.
Statistically significant parameter estimates are highlighted in bold face.
We found a moderate negative association between FSH and
divided attention at premenstrual phase during the first cycle,
but that finding was not replicated using data from the second
cycle. Moreover, this effect was not evident when specifically
focusing on intra-individual change over time. The analysis of
change scores is the more stringent test of a causal pathway than
between-subject effects, though even this test can be confounded
by random variance in hormone concentrations or systematic
bias due to practice effects. More specifically, intra-individual
change in progesterone levels and blockspan backwards were
substantially associated from pre-ovulatory to mid-luteal phase
during the first cycle, but unrelated during the second cycle. In
addition, changes in testosterone were significantly related to
changes in divided attention from menstrual to pre-ovulatory
as well as from pre-ovulatory to mid-luteal phase. Again, these
associations failed to replicate in the second cycle, which stresses
how easily irreproducible false-positive findings can emerge
in neuroendocrinological research (Rosmalen and Oldehinkel,
2011; Hengartner, 2017).
Another particularly striking example for inconsistent false-
positive findings in small samples was provided by our subset
analysis of healthy women. With respect to estrogen, we found
two significant between-subejct effects during the first cycle.
However, analyses using data from the second cycle did not
replicate these findings. Moreower, there was evidence for one
significant within-subject effect of estrogen over the course
of the first cycle, but again that finding was inconsistent
with data from the second cycle. Replication of anecdotal
findings using data from a second cycle as implemented in
the present study is therefore necessary in order to increase
confidence in the reliability of neuroendocrinological findings.
Another stringent approach would be to test hypotheses using
randomized controlled trials. For instance, the popular “window
of opportunity” hypothesis (e.g., Sherwin, 2012), which states
that estrogen therapy may protect against cognitive decline
only when initiated shortly after menopause, was in the
meantime unequivocally refuted by a randomized, double-blind,
placebo-controlled trial (Henderson et al., 2016). This trial
did in fact also challange the sexual dimorphism hypothesis
(e.g., Farage et al., 2008), since hormone therapy did not
differentially influence verbal memory relative to placebo
(Henderson et al., 2016).
Practice effects (Collie et al., 2003; Bartels et al., 2010) were
observed with respect to associations between intra-individual
change scores in divided attention and testosterone (see Table 4).
Because divided attention improved substantially during the
first half of the cycle (i.e., from menstrual to pre-ovulatory and
from pre-ovulatory to mid-luteal phase) due to practice effects
while testosterone remained stably low during the same time-
period, our data revealed a spurious negative association between
these measures of change during the first cycle. In accordance,
when we tried to replicate these findings with data from the
second cycle, where practicing did no longer exert an effect
on divided attention (see Table 2), those artefactual associations
between testosterone and divided attention disappeared. As
a consequence, many published studies use counterbalanced
designs to minimize confounding by practice effects. However,
it is important to recognize that the specific timing of the
first test application still introduces a major bias even in
counterbalanced test-sequencing designs. Imagine for instance a
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TABLE 3 | Associations between inter-individual differences in prefrontal cognitive test scores and hormone levels across the first cycle.
Cognitive Test Hormones Measurement
Menstrual Pre-ovulatory Mid-luteal Premenstrual
β (SE) β (SE) β (SE) β (SE)
Blockspan forwards Estrogen 0.04 (0.15) −0.10 (0.11) −0.10 (0.15) −0.29 (0.10)
Progesterone 0.00 (0.12) −0.01 (0.10) −0.02 (0.07) −0.16 (0.10)
LH 0.42 (0.32) −0.29 (0.22) 0.17 (0.33) 0.44 (0.24)
FSH 0.01 (0.26) 0.02 (0.07) 0.27 (0.29) 0.06 (0.20)
Testosterone −0.00 (0.14) 0.00 (0.12) −0.08 (0.10) 0.09 (0.14)
Blockspan backwards Estrogen −0.06 (0.09) −0.02 (0.10) −0.12 (0.12) −0.02 (0.11)
Progesterone −0.01 (0.07) −0.14 (0.10) −0.21 (0.16) −0.13 (0.12)
LH 0.36 (0.50) −0.22 (0.17) 0.52 (0.31) 0.52 (0.32)
FSH −0.14 (0.30) −0.65 (0.36) 0.12 (0.19) 0.36 (0.25)
Testosteronea −0.07 (0.10) −0.12 (0.10) 0.18 (0.09) 0.21 (0.13)
Cognitive bias Estrogen 0.16 (0.10) 0.04 (0.07) −0.03 (0.08) 0.05 (0.06)
Progesterone −0.20 (0.09) −0.11 (0.08) −0.08 (0.10) 0.01 (0.07)
LH −0.05 (0.22) 0.28 (0.16) 0.14 (0.16) −0.04 (0.10)
FSH −0.21 (0.12) 0.03 (0.15) 0.00 (0.13) −0.19 (0.08)
Testosterone −0.14 (0.10) −0.06 (0.09) −0.06 (0.13) 0.02 (0.10)
Divided attention Estrogen −0.12 (0.15) 0.07 (0.07) 0.01 (0.12) 0.05 (0.08)
Progesterone −0.11 (0.11) −0.03 (0.11) 0.03 (0.10) 0.05 (0.08)
LH −0.62 (0.27) −0.23 (0.17) −0.30 (0.19) 0.38 (0.20)
FSHb −0.01 (0.20) −0.12 (0.13) 0.11 (0.11) −0.29 (0.10)*
Testosterone −0.04 (0.10) −0.10 (0.09) −0.19 (0.11) 0.01 (0.09)
aStatistically significant model effect at p = 0.031.
bStatistically significant model effect at p = 0.010.
*Statistically significant parameter at Bonferroni corrected α = 0.008.
Statistically significant parameter estimates are highlighted in bold face.
cognitive test that is absolutely unrelated to hormone levels but
whose scores are known to increases at retest due to practice
effects. Now assume that half of a sample completes this cognitive
test first at menstrual phase and the other three assessments
consecutively at pre-ovulatory, mid-luteal and premenstrual
phase, while the second group starts cognitive testing at mid-
luteal phase. In the first group the practice effect runs parallel
with stably low progesterone levels, while in the second group it
is accompanied by a steep decrease from very high progesterone
to moderately high levels during luteal phase. It comes without
saying that this particular sequencing conveys a strong bias on the
progesterone-cognition associations by producing a negligible
positive interaction with time in the first group, but a strong
negative interaction in the second. Pooled over both groups, this
bias would result in a moderate negative association between
cognitive ability and progesterone. Thus, obviously this effect
is not counterbalanced between groups, which is why balanced
sequencing of neurocognitive testing cannot eliminate practice
effects.
Finally, we acknowledge the following limitations: firstly,
though our sample was considerably larger than those commonly
assessed in this field, a sample size of n> 100 would be preferable
due to the substantial variance in hormone levels at given time
points. Secondly, though to the best of our knowledge we were
the first to use data from a second cycle as an external validation
criterion, that sample consisted of a subset of women from the
first cycle. Therefore, this data from the second cycle was not
independent from data from the first cycle. In future research
it would be worthwhile to assess an independent validation
sample. Thirdly, we assessed only three cognitive functions, that
is, visuospatial working memory, divided attention and cognitive
bias, which are certainly not exhaustive and hence do not
cover the whole range of cognitive functioning. Consideration
of additional tests would be preferable with respect to coverage,
but note that increasing the number of cognitive tests would
also increase the probability of false-positive chance findings
due to multiple testing. Fourthly, 30 women (34.1%) presented
with endocrinological disorders and therefore their hormone
levels may deviate from healthy controls. However, statistical
control for endocrinological disorders did not alter the results
and a subset analysis of healthy women did not indicate
any consistent findings either. It is also worth noting that
endocrinological disorders should not affect the association
between hormone levels and cognitive ability, unless there would
be stringent evidence that in women with endocrinological
disorders hormones serve a different function than in healthy
women. Finally, fifthly, we did not incorporate a counterbalanced
design. Even though we believe that practice effects were ruled
out in the second cycle, it could be worthwhile to combine a
repeated cycle design with counterbalancing of test sequences.
CONCLUSIONS
Our results indicate that the literature on associations
between hormonal changes during the menstrual cycle and
cognitive functioning is prone to inflated effect sizes and
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TABLE 4 | Associations between intra-individual changes in prefrontal cognitive
test scores and changes in hormone levels across the first cycle.
Cognitive
test
Hormones Measurement
T1 thru T2 T2 thru T3 T3 thru T4
β (SE) β (SE) β (SE)
Blockspan
forwards
Estrogen −0.12 (0.12) −0.18 (0.12) −0.14 (0.15)
Progesterone −0.02 (0.14) −0.10 (0.12) 0.00 (0.11)
LH −0.11 (0.19) −0.10 (0.16) 0.31 (0.19)
FSH −0.03 (0.13) 0.10 (0.15) 0.09 (0.15)
Testosterone −0.17 (0.15) −0.02 (0.15) 0.01 (0.15)
Blockspan
backwards
Estrogen −0.02 (0.10) −0.15 (0.16) −0.06 (0.17)
Progesteronea −0.04 (0.16) −0.44 (0.14)* 0.02 (0.19)
LH −0.04 (0.16) −0.01 (0.16) 0.33 (0.16)
FSH −0.14 (0.12) 0.14 (0.16) 0.30 (0.21)
Testosterone 0.15 (0.14) 0.22 (0.12) −0.04 (0.11)
Cognitive bias Estrogen 0.14 (0.13) 0.01 (0.07) 0.02 (0.13)
Progesteroneb −0.21 (0.12) −0.31 (0.12) −0.07 (0.14)
LH −0.06 (0.13) 0.00 (0.15) 0.03 (0.13)
FSH 0.03 (0.10) −0.03 (0.14) −0.02 (0.13)
Testosterone −0.17 (0.13) −0.01 (0.12) −0.00 (0.08)
Divided
attention
Estrogen −0.11 (0.14) 0.06 (0.13) 0.10 (0.14)
Progesteronec −0.39 (0.15) 0.13 (0.09) 0.09 (0.13)
LH −0.15 (0.08) 0.16 (0.21) 0.06 (0.12)
FSH −0.12 (0.10) −0.01 (0.12) −0.04 (0.16)
Testosteroned −0.24 (0.09)* −0.34 (0.12)* 0.01 (0.13)
aStatistically significant model effect at p = 0.010.
bStatistically significant model effect at p = 0.009.
cStatistically significant model effect at p = 0.025.
dStatistically significant model effect at p = 0.001.
*Statistically significant parameter at Bonferroni corrected α = 0.008.
T1, Menstrual phase; T2, pre-ovulatory phase; T3, mid-luteal phase; T4, premenstrual
phase.
Statistically significant parameter estimates are highlighted in bold face.
probable false-positive findings due to methodological biases
and random variance. In the present study we found no
consistent and meaningful associations between prefrontal
cognitive functioning and fluctuations in hormone levels that
replicated across two menstrual cycles, considering both inter-
individual differences and intra-individual change. Regarding
the inconsistencies in the published literature and the various
methodological limitations in studies with positive results, we
suggest that caution is warranted when conclusions are made for
specific hormonal effects on cognitive functioning. The results
of the present observational study based on two consecutive
cycles with four assessments each and the findings of other
observational studies (e.g., Mordecai et al., 2008; Griksiene and
Ruksenas, 2011) as well as a recent randomized controlled trial
(Henderson et al., 2016) all showed that estrogen did not relate
to global cognitive functioning, including attention, cognitive
control, and sexually dimorphic tasks such as visuospatial
working memory or verbal fluency. To rule out confounding
by practice effects and to minimize the probability of false-
positive chance findings, observational studies should stringently
include data from a second cycle. Moreover, more emphasis
on intra-individual change in hormone levels is required, as
within-subject effects have been largely neglected in this field
thus far.
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